Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02668666
Title Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oana Danciu, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Michigan State University Lansing Michigan 48910 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
University of Wisconsin Madison Wisconsin 53705 United States Details
ProHealth Care Waukesha Wisconsin 53188 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field